Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,107.33
(
0.61%
)
US TECH 100
25,952.40
(
0.70%
)
Dow Jones
49,504.03
(
0.11%
)
Brent Oil
95.83
(
0.86%
)
Bitcoin
78,769.56
(
3.20%
)
News Focus
News Focus
Post# of 257435
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: EyeGuy post# 41525

Friday, 02/02/2007 2:30:08 PM

Friday, February 02, 2007 2:30:08 PM

Post# of 257435
>The company's assertion that "ATG3 is the first non-invasive eye drop therapy for AMD that has entered the clinic..." is not completely true.<

Yes, they were sloppy to have said “AMD” when they ought to have said wet AMD. Thanks for reminding us about Othera.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up